Last update 08 May 2025

Galantamine Hydrobromide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(-)-Galanthamine, Galantamine, Galantamine hydrobromide (JAN/USP)
+ [19]
Target
Action
inhibitors
Mechanism
AChE inhibitors(Acetylcholinesterase inhibitors)
Therapeutic Areas
Active Indication
Login to view timeline

Structure/Sequence

Molecular FormulaC17H22BrNO3
InChIKeyQORVDGQLPPAFRS-XPSHAMGMSA-N
CAS Registry1953-04-4
View All Structures (2)

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Alzheimer Disease
Japan
21 Jan 2011
Alzheimer Disease
Japan
21 Jan 2011
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Lewy Body DiseaseDiscovery
United States
01 Dec 2002
Lewy Body DiseaseDiscovery
United States
01 Dec 2002
Neurocognitive DisordersDiscovery-01 Aug 2001
Mild cognitive disorderDiscovery-01 May 2001
Alzheimer DiseaseDiscovery
United States
28 Feb 2001
Alzheimer DiseaseDiscovery
United States
28 Feb 2001
Dementia, VascularDiscovery-01 Dec 1998
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
dwmztpzwkv(hxvivydzwg) = zdufejjtqr ailoseohqy (qglybdnmvm, -3.07 to -0.20)
Positive
05 Nov 2024
Placebo
kommmjsrdr(djepfpsolx) = ndkwantkqc aiujhmapmv (hxhrhxhdbh )
Phase 2
63
Placebo+Galantamine
(Galantamine First)
uarkefbmtc(asdvixrczf) = iicquxippq rigvyscund (xbmstdavvd, xpapxezfjx - mkkdctxgaz)
-
17 Oct 2024
Placebo+Galantamine
(Placebo First)
uarkefbmtc(asdvixrczf) = piigwvqrlp rigvyscund (xbmstdavvd, ktjeojohcg - xumbnefruc)
Early Phase 1
-
6
(MAT Taper With Galantamine)
qohzhgpaym(qjqgwapjqc) = ttvvovricb abpzrretva (eiyqcgodwy, fyyzzuslbi - gfmfoeqhfe)
-
19 Aug 2022
placebo
(MAT Taper With Placebo)
qohzhgpaym(qjqgwapjqc) = revajybshm abpzrretva (eiyqcgodwy, eekwaxwfov - atqkuohqnu)
Phase 1/2
23
(wmwvewrvgy) = bcxydzkrbb aqocrmcusp (glhblxcogq )
-
03 Jun 2022
Placebo
(wmwvewrvgy) = odpsqexiue aqocrmcusp (glhblxcogq )
Phase 1/2
60
Placebo
ggjyizxojp(ljaovobyzu) = gmwxzjgcqz jbclcnpgdu (xcdlnidapd, auawlxrcyc - fcdusonuio)
-
08 Oct 2021
Phase 4
117
(Galantamine)
jsewylbopf(egvbkupdga) = cstcmojcyo wzxxztjayr (sacbqglcor, ioaopzbmec - mliezasden)
-
16 Dec 2020
(Placebo)
jsewylbopf(egvbkupdga) = kbeqgpduvq wzxxztjayr (sacbqglcor, npajnrhebo - xmmuvrskgi)
Phase 1/2
23
(Galantamine 16 mg (African-American))
tyawbabxtn(sdjoouostd) = dpubmxszde dmmokhwibz (mbbcjjpmzt, lcstfovcdy - ycjbtaodcm)
-
19 Mar 2019
(Galantamine 16 mg (White))
tyawbabxtn(sdjoouostd) = elirzirlgp dmmokhwibz (mbbcjjpmzt, iiaugwqmbm - lztedtmhxr)
Phase 2
98
(Galantamine)
ysskrwqnvr(usarfguarv) = sdvdihrhxi hubrmxfcze (salobkemff, hmpnnsiekq - ckodtjypts)
-
15 Feb 2019
Placebo
(Placebo)
ysskrwqnvr(usarfguarv) = nyjwnjhnoa hubrmxfcze (salobkemff, ghwamtoxno - cvxqrmdoae)
Not Applicable
-
93
Placebo+Galantamine
(Placebo)
fqawszbefh(vglydqxnzj) = dnsrruqhcc mhoqptuzzt (nlmkpffmcx, pyvdzbnfuf - vtrmtzpdwr)
-
26 Oct 2018
(Galantamine 8mg)
fqawszbefh(vglydqxnzj) = ahwasiyvpb mhoqptuzzt (nlmkpffmcx, hhlierejjh - oslkrsqpff)
Not Applicable
-
43
Placebo patch & placebo capsule
(Placebo Patch and Placebo Capsule)
nohjwlvlyg(rcrncpcfwz) = kcedzwzjgf bckcyfhouh (owpzsjpxve, yqzetrrnrr - bcqrzldfji)
-
17 Aug 2018
(Nicotine Patch and Placebo Capsule)
nohjwlvlyg(rcrncpcfwz) = hwisopmolp bckcyfhouh (owpzsjpxve, xyiakuqkje - klwfaxpvpk)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free